Merck & CompanyvsViemed Healthcare

MRK and VMD stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$144.46

Value $357B

-2.23%
MRK's page

VMD

Viemed Healthcare, Inc.

$9.15

Value $353M

-0.22%
VMD's page

Merck & Company (MRK) has a market value of $357B and Viemed Healthcare (VMD) $353M. Over the last year, with dividends, MRK moved +60.0% and VMD +43.2%. The P/E is 145.6 for MRK and 22.6 for VMD. Dividend yield: MRK 2.35%, VMD none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MRK$357B

    VMD$353M

    MRK is 1,011 times VMD

  • Revenue, 12 months

    MRK$67.4B

    VMD$310M

    MRK is 217 times VMD

  • Net income, 12 months

    MRK$2.5B

    VMD$16M

    MRK is 157 times VMD

  • Operating margin

    MRK–

    VMD7.8%

  • ROIC

    MRK3.9%

    VMD11.1%

    7.2 points apart

  • P/E

    MRK145.6

    VMD22.6

    MRK is 6.4 times VMD

  • Dividend yield

    MRK2.4%

    VMD0.0%

    2.4 points apart

  • 5-year return

    MRK+101.1%

    VMD+59.7%

    41.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MRK+101.1%

VMD+59.7%

10015020020222023202420252026
Returns by period
PeriodMRKWith dividendsVMDWith dividends
1 year since November 14, 2025+60.0%Price +55.5%+43.2%Price +43.2%
3 years since November 16, 2023+55.2%+15.8% a yearPrice +41.6%+24.0%+7.4% a yearPrice +24.0%
5 years since November 15, 2021+101.1%+15.0% a yearPrice +72.6%+59.7%+9.8% a yearPrice +59.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MRKMerck & CompanyVMDViemed Healthcare

Valuation

MRKVMD
Valuation
Price$144.46$9.15
Market value$357B$353M
Enterprise value (EV)$401B$349M
P/E145.622.6
P/E, 5-year median14.828.6
P/B8.02.4
EV/EBIT84.314.5
Free cash flow yield4.1%6.1%

Results and growth

MRKVMD
Results and growth
Revenue, 12 months$67.4B$310M
Net income, 12 months$2.5B$16M
Free cash flow, 12 months$14.7B$21M
Earnings per share, 12 months$0.98$0.38
Revenue growth, year on year1.3%20.5%
Revenue growth a year, past+9.4%over 5 years+15.5%over 5 years
EPS growth a year, past+21.2%over 5 years-13.9%over 5 years

Margins and returns on capital

MRKVMD
Margins and returns on capital
Gross margin71.8%57.4%
Operating margin–7.8%
Net margin3.6%5.0%
ROIC3.9%11.1%
ROE5.2%11.0%

Balance sheet

MRKVMD
Balance sheet
Cash$9.7B$9.7M
Total debt$53.8B$9.3M
Net debt / EBITDA5.7-0.1
Interest cover2.4×–

Dividends and buybacks

MRKVMD
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$3.40–
Dividend growth a year, past+5.8%over 5 years–
Buyback yield1.4%3.7%
Shareholder yield3.8%3.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MRK or VMD

Didn't find what you were looking for?

Ask us
Which is bigger, Merck & Company or Viemed Healthcare?

By market value, Merck & Company ($357B) is about 1,011.2 times Viemed Healthcare ($353M), at today's prices.

How did MRK and VMD stock do over the last 5 years?

Since November 15, 2021, MRK's price moved +72.6% and VMD's +59.7%. With dividends: MRK +101.1% (+15.0% a year), VMD +59.7% (+9.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, MRK or VMD?

The dividend yield at today's price is 2.35% for Merck & Company and none for Viemed Healthcare. Over the last twelve months they paid $3.40 and – per share.

What is the P/E of MRK and VMD?

At today's price, the P/E is 145.6 for MRK and 22.6 for VMD. The median of the last five years was 14.8 and 28.6, which shows where each stands against its own past.

Which has the higher profit margins, Merck & Company or Viemed Healthcare?

Over the last twelve months, the net margin was 3.6% for Merck & Company and 5.0% for Viemed Healthcare, and the operating margin – and 7.8%. Revenue was $67.4B and $310M.

Which is the better investment, Merck & Company or Viemed Healthcare?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.